Skip to main content

Table 9 Predictors of stocking of DHAPQ-ACT by PPMVs

From: Stocking pattern for anti-malarial medications among proprietary patent medicine vendors in Akinyele Local Government Area, Ibadan, Nigeria

Variables

Dihydroartemisinin (DHAPQ) in yes n (%)

Piperaquine stock no n (%)

X2 (p-value)

OR (95% CI)

Health-related qualification

 No health qualification (ref)

14 (4.6)

292 (95.4)

  

 Has health qualification

3 (21.4)

11 (78.6)

7.56 (0.006)*

5.69 (1.42–22.72)

Manufacturer as the source of purchase of anti-malarial

 No (ref)

16 (5.1)

300 (94.9)

  

 Yes

1 (25.0)

3 (75.0)

3.12 (0.077)

6.25 (0.62–63.49)

Sales representatives as a source of information on government recommended anti-malarial medication

 No (ref)

14 (4.6)

289 (95.4)

  

 Yes

3 (17.6)

14 (82.4)

5.43 (0.020)*

4.42 (1.14–17.19)

PPMV knew the national recommended guideline for malaria diagnosis

 Incorrect knowledge (ref)

15 (4.8)

297 (95.2)

  

 Correct knowledge

2 (25.0)

6 (75.0)

6.32 (0.012)*

6.60 (1.23–35.49)

PPMV used malaria diagnostic tool

 No (ref)

14 (4.7)

286 (95.3)

  

 Yes

3 (15.0)

17 (85.0)

3.98 (0.046)

3.61 (0.94–13.76)

  1. Ref reference category
  2. * Significant p-value